Joerg Kallen

4.8k citations

58 papers · 3.6k indexed · 1 hit paper · h-index 31

Impact in

Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Immunology top 5%

Papers in

Toxicology 3
Immunology and Allergy 5
- Cell Adhesion Molecules Research 5

Co-authors: Sylvain Cottens Karl Welzenbach Gabriele Weitz‐Schmidt Ulrich Hommel Brigitte Fournier Malcolm D. Walkinshaw Jean-Marc Schlaeppi Francis Bitsch
Journals: Bioorganic & Medicinal Chemistry Letters (8 papers)Journal of Biological Chemistry (6 papers)ChemMedChem (5 papers)Journal of Molecular Biology (5 papers)FEBS Letters (4 papers)
Partner nations: Switzerland United States United Kingdom

In The Last Decade

Joerg Kallen

57 papers receiving 3.5k citations

Hit Papers

align trajectories log scale

Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site 2001 · 844 citations

Peers

Countries citing papers authored by Joerg Kallen

Since Specialization

Citations

This map shows the geographic impact of Joerg Kallen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Kallen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Kallen more than expected).

Fields of papers citing papers by Joerg Kallen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Kallen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Kallen. The network helps show where Joerg Kallen may publish in the future.

Co-authors

The 25 scholars most cited alongside Joerg Kallen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joerg Kallen Line = papers co-authored together Joerg Kallen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	p53 dynamics vary between tissues and are linked with radiation sensitivity Nature Communications ·Jacob Stewart-Ornstein, Yoshiko Iwamoto, Miles A. Miller, Mark Prytyskach, Stéphane Ferretti, Philipp Holzer, Joerg Kallen, Pascal Furet, Ashwini Jambhekar, William C. Forrester, Ralph Weissleder, Galit Lahav	2021	54
2	Molecular and structural characterization of a TEAD mutation at the origin of Sveinsson's chorioretinal atrophy FEBS Journal ·Fedir Bokhovchuk, Yannick Mesrouze, Aude Izaac, Marco Meyerhofer, Catherine Zimmermann, Patrizia Fontana, Tobias Schmelzle, Dirk Erdmann, Pascal Furet, Joerg Kallen, Patrick Chêne	2019	21
3	Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53–MDM2 interaction with a distinct binding mode Bioorganic & Medicinal Chemistry Letters ·F. Gessier, Joerg Kallen, Edgar Jacoby, Patrick Chêne, Therese‐Marie Stachyra, Stephan Ruetz, Sébastien Jeay, Philipp Holzer, Keiichi Masuya, Pascal Furet	2015	47
4	The central valine concept provides an entry in a new class of non peptide inhibitors of the p53–MDM2 interaction Bioorganic & Medicinal Chemistry Letters ·Pascal Furet, Patrick Chêne, Alain De Pover, Therese‐Marie Stachyra, Joanna Lisztwan, Joerg Kallen, Keiichi Masuya	2012	52
5	6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists Bioorganic & Medicinal Chemistry Letters ·David Orain, Silvio Ofner, Manuel Koller, David A. Carcache, Wolfgang Froestl, Hans Allgeier, Vittorio Rasetti, Joachim Nozulak, Henri Mattes, Nicolas Soldermann, Philipp Floersheim, Sandrine Desrayaud, Joerg Kallen, Kurt Lingenhoehl, Stephan Urwyler	2011	16
6	Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity Bioorganic & Medicinal Chemistry Letters ·Manuel Koller, Kurt Lingenhoehl, Markus Schmutz, Ivan-Toma Vranesic, Joerg Kallen, Yves P. Auberson, David A. Carcache, Henri Mattes, Silvio Ofner, David Orain, Stephan Urwyler	2011	33
7	Crystal Structures of Human MdmX (HdmX) in Complex with p53 Peptide Analogues Reveal Surprising Conformational Changes Journal of Biological Chemistry ·Joerg Kallen, A. Goepfert, Anke Blechschmidt, Aude Izaac, Martin Geiser, Gisele Tavares, Paul Ramage, Pascal Furet, Keiichi Masuya, Joanna Lisztwan	2009	63
8	Knowledge-Based Virtual Screening: Application to the MDM4/p53 Protein–Protein Interaction Methods in molecular biology ·Edgar Jacoby, Andreas Boettcher, Lorenz M. Mayr, Nathan Brown, Jeremy L. Jenkins, Joerg Kallen, Caroline Engeloch, Ulrich Schopfer, Pascal Furet, Keiichi Masuya, Joanna Lisztwan	2009	17
9	Crystal Structure of Human Estrogen-related Receptor α in Complex with a Synthetic Inverse Agonist Reveals Its Novel Molecular Mechanism Journal of Biological Chemistry ·Joerg Kallen, René Lattmann, René Beerli, Anke Blechschmidt, Marcel J. J. Blommers, Martin Geiser, Johannes Ottl, Jean-Marc Schlaeppi, André Strauss, Brigitte Fournier	2007	76
10	Structure of Human Cyclophilin A in Complex with the Novel Immunosuppressant Sanglifehrin A at 1.6 Å Resolution Journal of Biological Chemistry ·Joerg Kallen, Richard Sedrani, Gerhard Zenke, Juergen Wagner	2005	39
11	Evidence for Ligand-independent Transcriptional Activation of the Human Estrogen-related Receptor α (ERRα) Journal of Biological Chemistry ·Joerg Kallen, Jean-Marc Schlaeppi, Francis Bitsch, Ireos Filipuzzi, Alain Schilb, Virginie Riou, Alexander Graham, André Strauss, Martin Geiser, Brigitte Fournier	2004	180
12	Improved Lymphocyte Function-associated Antigen-1 (LFA-1) Inhibition by Statin Derivatives Journal of Biological Chemistry ·Gabriele Weitz‐Schmidt, Karl Welzenbach, Janet Dawson, Joerg Kallen	2004	55
13	1,4-Diazepane-2,5-diones as novel inhibitors of LFA-1 Bioorganic & Medicinal Chemistry Letters ·Sompong Wattanasin, Joerg Kallen, Stewart Myers, Qin Guo, Michael Sabio, Claus Ehrhardt, Rainer Albert, Ulrich Hommel, Gisbert Weckbecker, Karl Welzenbach, Gabriele Weitz‐Schmidt	2004	34
14	X-Ray Structure of the hRORα LBD at 1.63 Å Structure ·Joerg Kallen, Jean-Marc Schlaeppi, Francis Bitsch, Sabine Geisse, Martin Geiser, Isabelle Delhon, Brigitte Fournier	2002	236
15	Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site Nature Medicine ·Gabriele Weitz‐Schmidt, Karl Welzenbach, Volker Brinkmann, Tetsji Kamata, Joerg Kallen, Christian Bruns, Sylvain Cottens, Yoshikazu Takada, Ulrich Hommel Hit paper breakdown →	2001	844
16	Conformational differences of an immunosuppressant peptolide in a single crystal and in a crystal complex with human cyclophilin A 1 1Edited by I. A. Wilson Journal of Molecular Biology ·V. Mikol, Paul Taylor, Joerg Kallen, Malcolm D. Walkinshaw	1998	12
17	Elucidation of Structure Function Relationships in the IL-8 Family by X-ray Crystallography Advances in experimental medicine and biology ·Manfred Auer, Susan R. Owens, Sabine Pfeffer, Joerg Kallen, Erich Wasserbauer, H.N. Aschauer, Gerald Ehn, Antal Rot, J Besemer, Charles Lam, I. J. D. Lindley	1993	1
18	The X‐ray structure of a tetrapeptide bound to the active site of human cyclophilin A FEBS Letters ·Joerg Kallen, Malcolm D. Walkinshaw	1992	109
19	Cyclosporin A—cyclophilin complex formation A model based on X‐ray and NMR data FEBS Letters ·Claus Spitzfaden, H. P. WEBER, Werner Braun, Joerg Kallen, Gerhard Wider, Hans Widmer, Malcolm D. Walkinshaw, Kurt Wüthrich	1992	89
20	Complexes of aspartate aminotransferase with hydroxylamine derivatives: spectral studies in solution and in the crystalline state Biochimie ·Louis T. J. Delbaere, Joerg Kallen, Z. Marković-Housley, Alex R. Khomutov, R. M. Khomutov, M.Ya. Karpeisky, Johan N. Jansonius	1989	11

About Joerg Kallen

Joerg Kallen is a scholar working on Toxicology, Immunology and Allergy, Oncology, Immunology and Cell Biology, having authored 58 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (13 papers), Signaling Pathways in Disease (11 papers), Toxin Mechanisms and Immunotoxins (7 papers), Hippo pathway signaling and YAP/TAZ (7 papers), Cell Adhesion Molecules Research (5 papers), Estrogen and related hormone effects (5 papers), Plant Surface Properties and Treatments (5 papers) and Cytokine Signaling Pathways and Interactions (4 papers). The work is most often cited by research in Immunology and Allergy (288 citations), Immunology (771 citations), Oncology (738 citations), Molecular Biology (1.9k citations) and Transplantation (68 citations). Joerg Kallen has collaborated with scholars based in Switzerland, United States and United Kingdom. Frequent co-authors include Sylvain Cottens, Karl Welzenbach, Gabriele Weitz‐Schmidt, Ulrich Hommel, Brigitte Fournier, Malcolm D. Walkinshaw, Jean-Marc Schlaeppi, Francis Bitsch, Volker Brinkmann and Christian Bruns. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Biological Chemistry, ChemMedChem, Journal of Molecular Biology and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact